SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001798749-23-000017
Filing Date
2023-03-29
Accepted
2023-03-29 17:10:06
Documents
4
Effectiveness Date
2023-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220815xs8.htm S-8 67699
2 EX-5.1 tmb-20220815xex5d1.htm EX-5.1 7263
3 EX-23.1 tmb-20220815xex23d1.htm EX-23.1 3960
4 EX-FILING FEES tmb-20220815xexfilingfees.htm EX-FILING FEES 29054
  Complete submission text file 0001798749-23-000017.txt   108988
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270950 | Film No.: 23776115
SIC: 2834 Pharmaceutical Preparations